Manulife (Manufacturers Life Insurance)
CLSD

Manulife (Manufacturers Life Insurance)’s Clearside Biomedical CLSD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-804
Closed -$74K – 2546
2018
Q3 		$74K Sell
804
-702
-47% -$83.4K ﹤0.01% 2911
2018
Q2 		$241K Buy
1,506
+370
+33% +$62.4K ﹤0.01% 2974
2018
Q1 		$183K Buy
1,136
+821
+261% +$100K ﹤0.01% 3082
2017
Q4 		$33K Sell
315
-904
-74% -$97K ﹤0.01% 3648
2017
Q3 		$159K Buy
1,219
+32
+3% +$3.91K ﹤0.01% 3159
2017
Q2 		$162K Buy
1,187
+1,182
+23,640% +$142K ﹤0.01% 3168
2017
Q1 		$1K Sell
5
-100
-95% -$11.8K ﹤0.01% 4022
2016
Q4 		$14K Buy
+105
New +$26.4K ﹤0.01% 3696

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CLSD Position: Q4 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Clearside Biomedical (CLSD) in Q4 2018, closing a stake of 804 shares — an estimated $74K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CLSD in Q4 2016 and held it in 8 quarters. The position peaked at $241K in Q2 2018. 69 funds tracked by Wall St. Rank hold CLSD as of Q4 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Clearside Biomedical position as of Q4 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 804 Clearside Biomedical shares in Q4 2018, an estimated $74K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Clearside Biomedical in Q4 2016 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s Clearside Biomedical position peaked at $241K in Q2 2018.
  • 69 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2018, filed 14 Feb 2019.